Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies 
Wall Street Ends Mixed as Micron Surges, Apple Drops After Price Hikes 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks 
Bank Regulation Rollbacks in the U.S. and UK Could Increase Financial Risks, Study Warns 
China Sets 1.25% Overnight Reverse Repo Rate Below Market Expectations 
Open-Source AI Models Gain Ground as Enterprises Seek Lower-Cost Alternatives, Citi Says 
Morgan Stanley Sees Chinese Auto Market Recovery Gaining Momentum in Late Summer 
Asian Stocks Slip as US-Iran Ceasefire Hopes Lift Oil, Dollar Strength Persists 
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms 
White House Seeks $87.6 Billion Emergency Funding for Iran War, Farmers, and Ebola Response 
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines 
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges 
Nomura Stock Upgraded to Buy by BofA as Stronger ROE and Earnings Growth Boost Outlook 
Gold Drops Below $4,000 as Strong US Dollar and Fed Rate Hike Expectations Pressure Bullion 
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook 
Juul, an American electronic cigarette company, will be ordered by the U.S. Food and Drug Administration (FDA) to remove its products from the local market. The said federal agency will soon ban the sale of the company’s sweet and fruity e-cigarette cartridges in the country.
According to Fox Business, the FDA is now preparing to hand over its order for Juul Labs Inc. to pull out its e-cigarette products from the U.S. market, and this was revealed by sources who are familiar with the matter.
It was reported that the agency may announce its decision as early as any time this week. The possible order of ban follows an almost two-year data review that was presented by Juul that was seeking permission to continue the sale of its tobacco and menthol-flavored products in the U.S.
Since the company started to be monitored by the FDA four years ago, Juul’s future fell into uncertainty. This was because its trendy marketing for its fruity vapes was blamed for the surge of underage vaping. Since then, the company has done its best to earn the trust of the public and regulators once again.
Juul limited its marketing campaign, and it stopped the sale of fruity and sweet flavors in 2019. However, the company’s sales have been declining in recent years.
At any rate, while Juul is close to being banned in the market, its rivals such as NJOY Holdings Inc. and Reynolds American Inc. managed to keep their similar products on the market. This was why business observers first thought that Juul would also get the same clearance.
With the imminent announcement of the ban from the FDA, it was said that Juul may pursue an appeal. The company may either challenge the agency’s decision in court or file a revised application for its product lines.
Meanwhile, Reuters reported that shares of Altria Group Inc. tobacco company, the parent of Juul, slid down by eight percent in morning trading following the reports of the FDA’s possible ban decision, which could be handed down this week.
